Singapore markets closed

Premier, Inc. (PINC)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
19.43-0.33 (-1.64%)
As of 11:44AM EDT. Market open.
Full screen
Trade prices are not sourced from all markets
Previous close19.76
Open19.70
Bid19.43 x 100
Ask19.44 x 100
Day's range19.27 - 19.80
52-week range18.65 - 28.30
Volume347,480
Avg. volume1,809,070
Market cap2.037B
Beta (5Y monthly)0.39
PE ratio (TTM)28.58
EPS (TTM)0.68
Earnings date07 May 2024
Forward dividend & yield0.84 (4.25%)
Ex-dividend date30 May 2024
1y target est21.67
  • Business Wire

    Premier, Inc. to Participate in BofA Securities Healthcare Conference on May 14, 2024

    CHARLOTTE, N.C., May 09, 2024--Premier, Inc. (NASDAQ: PINC), a leading technology-driven healthcare improvement company, today announced that members of its management team will participate in a fireside chat at the BofA Securities Healthcare Conference on Tuesday, May 14, 2024, at 9:20 a.m. PDT (12:20 p.m. EDT).

  • Insider Monkey

    Premier, Inc. (NASDAQ:PINC) Q3 2024 Earnings Call Transcript

    Premier, Inc. (NASDAQ:PINC) Q3 2024 Earnings Call Transcript May 7, 2024 Premier, Inc. misses on earnings expectations. Reported EPS is $-0.36161 EPS, expectations were $0.47. Premier, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good morning, and welcome to […]

  • Business Wire

    Premier, Inc. Announces Cross-Industry Initiative to Improve Diagnosis and Care for Chronic Kidney Disease

    CHARLOTTE, N.C., May 08, 2024--Premier, Inc. (NASDAQ: PINC) is excited to announce a strategic partnership with AstraZeneca called Uncover CKD - Care Collective aiming to identify patients with undiagnosed clinical chronic kidney disease (CKD); raise awareness of undiagnosed CKD among healthcare providers; and inform U.S. health systems that want to improve or develop and implement their strategies for CKD diagnosis, treatment and management.